Dr. Charles E Kelly, D.O. Internal Medicine - Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 820 Byron Rd, Ste 200, Howell, MI 48843 Phone: 517-548-1246 Fax: 517-548-9164 |
News Archive
The Gateway for Cancer Research announces an exciting new Gateway-funded phase II study using ADAPT therapy for treatment of metastatic colorectal cancer based on a 2010 AACR presentation by Dr. Lin and his collaborators.
Recent clinical trials have indicated that immune checkpoint blockade (ICB) therapy, which is designed to unleash a patient's immune system to attack cancer, has been revolutionary in its implications for breast cancer treatment, especially for its potential to treat patients with triple negative breast cancer.
Covalon Technologies Ltd., an advanced medical technologies company, is delighted to announce its financial results for its second quarter ended March 31, 2015, which includes revenue for three months of $2,180,276 and net income for the quarter of $264,340.
Changes in the epigenome, including chemical modifications of DNA, can act as an extra layer of information in the genome, and are thought to play a role in learning and memory, as well as in age-related cognitive decline.
› Verified 5 days ago